Despite the slowdown in dealmaking, French drugmaker Sanofi on Monday agreed to buy immunology-focused biotech Blueprint Medicines in a deal worth up to $9.5bn and Bristol Myers Squibb struck an up to ...

Merck & Co., Inc. (NYSE: MRK) has explored a potential acquisition of Swiss biotech firm MoonLake Immunotherapeutics in a ...

For decades, things went well for Bellevue Group. But now the sector weakness in biotechs could lead to losses.

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

Swiss biotechnology companies are stepping up expansion and investments in China, eyeing its huge market potential and improved policies to accommodate foreign capital, said executives and ...

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

The five-year levies on Vitamin-A Palmitate and Insoluble Sulphur follow findings that the substances were being dumped at ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

The Swiss economy grew slightly more strongly than initially expected in the first quarter of 2025. Real gross domestic ...

Swissport is expanding its presence at EuroAirport Basel Airport with the addition of 800 sq m of new freight space in ...

Late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease ...